Adrenal carcinoma as the first manifestation of a Li‑Fraumeni syndrome in three paediatric patients.

Adrenal Cortex Neoplasms / complications Adrenocortical Carcinoma / complications Child Humans Li-Fraumeni Syndrome / complications Tumor Suppressor Protein p53
Li-Fraumeni syndrome adrenal carcinoma paediatric virilization

Journal

Endokrynologia Polska
ISSN: 2299-8306
Titre abrégé: Endokrynol Pol
Pays: Poland
ID NLM: 0370674

Informations de publication

Date de publication:
2022
Historique:
received: 14 12 2021
accepted: 20 01 2022
pubmed: 21 5 2022
medline: 8 9 2022
entrez: 20 5 2022
Statut: ppublish

Résumé

Not required for clinical vignette.

Identifiants

DOI: 10.5603/EP.a2022.0021 PMID: 35593669
pubmed: 35593669
pii: VM/OJS/J/87389
doi: 10.5603/EP.a2022.0021
doi:

Substances chimiques

Tumor Suppressor Protein p53 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

788-789

Auteurs

Fernando Mendonça (F)

Department of Endocrinology, Diabetes, and Metabolism, São João University and Hospital Centre, Porto, Portugal. fernandomiguel_92@hotmail.com.

Ana Bernardo Ferreira (AB)

Pediatrics and Neonatology Department, Entre Douro e Vouga Hospital Centre, Santa Maria da Feira, Portugal.

Filipa Pinto (F)

Pediatric Department, Médio Ave Hospital Centre, V.N.Famalicão, Portugal.

Alice Vasconcelos (A)

Genetics Department, São João University and Hospital Centre, Porto, Portugal, Portugal.

Sofia Ferreira (S)

Pediatric Endocrinology Unit, Paediatrics Department, Maternal and Paediatrics Centre, São João University and Hospital Centre, Porto, Portugal, Portugal.

Elisabete Rodrigues (E)

Department of Endocrinology, Diabetes, and Metabolism, São João University and Hospital Centre, Porto, Portugal.

Cíntia Castro-Correia (C)

Pediatric Endocrinology Unit, Paediatrics Department, Maternal and Paediatrics Centre, São João University and Hospital Centre, Porto, Portugal, Portugal.

Maria João Gil-da-Costa (MJ)

Pediatric Oncology Department, São João University and Hospital Centre, Porto, Portugal.

Maria Bom-Sucesso (M)

Pediatric Oncology Department, São João University and Hospital Centre, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Tumeurs corticosurrénaliennes › Adrenal carcinoma as the first manifestation...
questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Tumeurs corticosurrénaliennes › Carcinome corticosurrénalien › Adrenal carcinoma as the first manifestation...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Adrenal carcinoma as the first manifestation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Adrenal carcinoma as the first manifestation...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Troubles dus à un défaut de réparation de l'ADN › Syndrome de Li-Fraumeni › Adrenal carcinoma as the first manifestation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Phosphoprotéines › Protéine p53 suppresseur de tumeur › Adrenal carcinoma as the first manifestation...